Physician

Kabir Jeewan Singh, M.D.

According to 2025 Medicare claims, Kabir Singh, M.D. (NPI: 1629233051) practices cardiology in the San Rafael, CA market, with the plurality of this provider's patient population coming from Marin, CA. This provider's primary affiliated billing organization is REGENTS UNIV OF CALIFORNIA UCSF (NPI: 1124439807; TIN: 943281662) and primary practice location at 94939-1142.

Singh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,816 traditional Medicare patients, billed 5,227 HCPCS/CPT codes, and received $310,659 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,368 prescription claims across 839 beneficiaries totaling $1,101,273 in drug costs, led by Eliquis (Apixaban). 2016 DME data shows 22 claims. Open Payments data shows 4 records totaling $264. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $83,312 to $1,101,273. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,471	3,537	$201,588
2016	1,468	3,643	$226,187
2017	1,495	3,788	$219,738
2018	1,473	3,753	$239,535
2019	1,877	4,156	$251,932
2020	1,528	3,457	$232,314
2021	1,709	4,316	$275,801
2022	1,440	3,448	$249,452
2023	1,621	3,880	$284,852
2024	1,816	5,227	$310,659

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	160	1,206	$83,312
2016	215	1,719	$150,995
2017	279	2,418	$279,214
2018	367	3,100	$434,656
2019	481	3,889	$605,178
2020	550	4,778	$821,989
2021	652	5,383	$910,485
2022	681	5,014	$925,314
2023	753	5,600	$1,038,284
2024	839	6,368	$1,101,273

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	22	$903
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	755	1,291	$103
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	180	409	$99
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	547	557	$53
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	648	1,043	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	297	320	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	393	26,705	$519,145
Xarelto	Rivaroxaban	153	10,243	$187,732
Repatha Sureclick	Evolocumab	81	5,020	$95,616
Praluent Pen	Alirocumab	42	2,526	$44,207
Entresto	Sacubitril/Valsartan	40	2,019	$40,715

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$264	HEARTFLOW, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kabir Jeewan Singh, M.D.?

Tedicare shows public-source Medicare data for Kabir Jeewan Singh, M.D. (NPI 1629233051), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kabir Jeewan Singh, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kabir Jeewan Singh, M.D.?

Kabir Jeewan Singh, M.D. is linked to REGENTS UNIV OF CALIFORNIA UCSF (billing NPI 1124439807) in the available physician profile data.

Does Kabir Jeewan Singh, M.D. have Open Payments data?

Kabir Jeewan Singh, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.